Indegene opens new center in Pune, boosts India presence

Bengaluru: Indegene, a digital-first life sciences commercialization company, has expanded its presence in India with the opening of a new center in Pune. "By leveraging the city’s highly skilled technology, management, and medical talent base, the company is enhancing its ability to help clients accelerate innovation, scale global operations, and deliver improved healthcare outcomes for patients worldwide," Indegene stated. Indegene Limited is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Its client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has about 5,000 employees worldwide, 9 operations hubs and 20 offices across North America, Europe, and Asia. In February, the company launched a new entity in Spain. Read also: Indegene appoints Pravin Rao, Dr Ashish Gupta and Jairaj Purandare as Independent Directors Indegene already has a significant presence in Europe, with centers in the UK, Germany, Ireland and Switzerland. Last year, Indegene acquired Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. In 2019, Indegene acquired DT Associates (now DT Consulting), a consulting services company in the UK that supports clients in the healthcare and life sciences space.